Impact of the COVID-19 Pandemic Regulations on the Health Status and Medical Care of Children with Trisomy 21

Abstract Background While children are considered at low risk for COVID-19, little is known about the impact of SARS-CoV-2 on paediatric risk patients like children with Trisomy 21 (T21). As these children often need regular therapy and various medical appointments, this study aimed to investigate the possible impact of the COVID-19 pandemic on children with T21. Patients and Methods Parents of children with T21 in the age of 0–12 years in Saxony-Anhalt were interviewed via phone in June 2021 regarding the health status and medical care of their children during the past 15 months of pandemic. Results 37 children with mean age of 6.1 years (min 0; max 12) were included in the study. The majority did not have any additional congenital anomalies. Surveyed parents hardly reported adverse changes of health status during the pandemic, but rather improvements, such as decreased number of respiratory infections and more time spend with their children. Outpatient appointments and therapy were cancelled or postponed at the onset of the pandemic, but parents reported low impact on their child’s health and development. The main concern seemed to be lack of childcare during school and day-care closures and uncertainty concerning possible health impacts of an infection on their children. Conclusion There was low impact of the COVID-19 pandemic on health and medical care of children with T21 in our study population. Further research is needed to help weigh the child’s individual risk of infection against the need for medical treatment and therapy when dealing with paediatric risk patients.

[1]  C. Lück,et al.  SARS-CoV-2 seroprevalence in students and teachers: a longitudinal study from May to October 2020 in German secondary schools , 2021, BMJ Open.

[2]  M. Lunghi,et al.  Impact of the COVID-19 Italian Lockdown on the Physiological and Psychological Well-Being of Children with Fragile X Syndrome and Their Families , 2021, International journal of environmental research and public health.

[3]  V. Camos,et al.  Severe effects of the COVID‐19 confinement on young children’s sleep: A longitudinal study identifying risk and protective factors , 2021, Journal of sleep research.

[4]  L. Weber,et al.  Prevalence of COVID-19 Among Children and Adolescents While Easing Lockdown Restrictions in Cologne, North Rhine-Westphalia, Germany , 2021, Klinische Pädiatrie.

[5]  E. Sanders,et al.  SARS-CoV-2 viral-load distribution reveals that viral loads increase with age: a retrospective cross-sectional cohort study. , 2021, International journal of epidemiology.

[6]  O. Doody,et al.  The reported effects of the COVID-19 pandemic on people with intellectual disability and their carers: a scoping review , 2021, Annals of medicine.

[7]  K. Donelan,et al.  Transition to virtual clinic: Experience in a multidisciplinary clinic for Down syndrome , 2021, American journal of medical genetics. Part C, Seminars in medical genetics.

[8]  Nicole M. Bouvier,et al.  Individuals with Down syndrome hospitalized with COVID-19 have more severe disease , 2020, Genetics in Medicine.

[9]  E. R. van den Heuvel,et al.  How did governmental interventions affect the spread of COVID-19 in European countries? , 2020, BMC Public Health.

[10]  A. Kantar,et al.  COVID-19 and children with Down syndrome: is there any real reason to worry? Two case reports with severe course , 2020, BMC Pediatrics.

[11]  M. Altable,et al.  Down’s syndrome and COVID-19: risk or protection factor against infection? A molecular and genetic approach , 2020, Neurological Sciences.

[12]  C. Klein,et al.  SARS-CoV-2 Triggering Severe Acute Respiratory Distress Syndrome and Secondary Hemophagocytic Lymphohistiocytosis in a 3-Year-Old Child With Down Syndrome , 2020, Journal of the Pediatric Infectious Diseases Society.

[13]  C. Klein,et al.  SARS-CoV-2 triggering severe ARDS and secondary HLH in a 3-year-old child with Down syndrome , 2020, Journal of the Pediatric Infectious Diseases Society.

[14]  J. Petty,et al.  The implications of face masks for babies and families during the COVID-19 pandemic: A discussion paper , 2020, Journal of Neonatal Nursing.

[15]  L. Fratiglioni,et al.  Impact of COVID-19-Related Lockdown on Psychosocial, Cognitive, and Functional Well-Being in Adults With Down Syndrome , 2020, Frontiers in Psychiatry.

[16]  R. Keogh,et al.  COVID-19 Mortality Risk in Down Syndrome: Results From a Cohort Study Of 8 Million Adults , 2020, Annals of Internal Medicine.

[17]  D. Taruscio,et al.  Clinical characteristics of individuals with Down syndrome deceased with CoVID‐19 in Italy—A case series , 2020, American journal of medical genetics. Part A.

[18]  C. Dame,et al.  [Consequences of the SARS-CoV-2 Pandemia on the Early Childhood Examinations]. , 2020, Klinische Padiatrie.

[19]  R. Jhaveri,et al.  Trisomy 21 and Coronavirus Disease 2019 in Pediatric Patients , 2020, The Journal of Pediatrics.

[20]  M. Altable,et al.  Down’s Syndrome and COVID-19: Risk or Protection Factor against Infection? , 2020 .

[21]  W. Chung,et al.  SARS-CoV-2 Infection in Patients with Down Syndrome, Congenital Heart Disease, and Pulmonary Hypertension: Is Down Syndrome a Risk Factor? , 2020, The Journal of Pediatrics.

[22]  C. Murray,et al.  COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study , 2020, The Lancet Child & Adolescent Health.

[23]  A. Villani,et al.  COVID‐19 and Down syndrome , 2020, Acta paediatrica.

[24]  A. Huppert,et al.  The role of children in the spread of COVID-19: Using household data from Bnei Brak, Israel, to estimate the relative susceptibility and infectivity of children , 2020, medRxiv.

[25]  R. Viner,et al.  School closure and management practices during coronavirus outbreaks including COVID-19: a rapid systematic review , 2020, The Lancet Child & Adolescent Health.

[26]  J. Ludvigsson Systematic review of COVID‐19 in children shows milder cases and a better prognosis than adults , 2020, Acta paediatrica.

[27]  C. Langenberg,et al.  SARS-CoV-2 (COVID-19): What Do We Know About Children? A Systematic Review , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  C. Dame,et al.  Auswirkungen der SARS-CoV-2 Pandemie auf die Früherkennungs-Untersuchungen bei Kindern , 2020, Klinische Pädiatrie.

[29]  F. Bianchi,et al.  Major congenital anomalies in babies born with Down syndrome: A EUROCAT population‐based registry study , 2014, American journal of medical genetics. Part A.

[30]  Lyubov Yevtushok,et al.  Twenty-year trends in the prevalence of Down syndrome and other trisomies in Europe: impact of maternal age and prenatal screening , 2012, European Journal of Human Genetics.